Rare diseases
Investigational molecules
Locations
Back to Bulgaria300 clinical trials in Pleven, Bulgaria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
BulgariaBulgariaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
BulgariaZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
BulgariaLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
BulgariaBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
BulgariaA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
BulgariaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
BulgariaA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
BulgariaLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
BulgariaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on viral respiratory infections, including studies of vaccines against RSV, human metapneumovirus, and influenza in older adults. Clinical trials aim to enhance protection against severe respiratory diseases.
Emphasis on vaccine efficacy and immune response in vulnerable populations.
Comprehensive studies addressing various skin conditions, with particular focus on psoriasis and hidradenitis suppurativa. Research includes both systemic and targeted therapies.
Innovative approaches in chronic skin condition management.
Advanced studies in cardiovascular disease prevention and treatment, including investigations into heart failure prevention and lipid management strategies.
Focus on preventive strategies and innovative therapeutic approaches.
Investigations into various autoimmune conditions, including multiple sclerosis and Sjögren's disease, exploring new therapeutic options and treatment approaches.
Emphasis on improving quality of life for patients with chronic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
